Filter
1306
Text search:
pharmaceutical
policies
Featured
120
360
Language
Document type
635
294
184
83
60
15
12
11
6
3
3
Countries / Regions
62
59
54
40
37
36
32
31
27
23
22
21
20
19
19
19
17
17
16
15
14
14
13
13
12
12
11
10
10
9
9
7
7
7
7
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
580
69
63
59
31
19
11
Toolboxes
159
103
102
72
69
45
34
32
31
26
23
22
22
19
14
13
11
9
7
5
4
4
3
3
1
The list of emergency medicine has been developed though various consultative meeting and workshops with concerned health professionals and institutions. The medicines in the list should be administered to emergency patients only treated in the health institutions, purchased from legal medicine reta
...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Bull World Health Organ 2017;95:594–598
Accessed November, 2017
Therapeutics Information and Pharmacovigilance Centre | TIPC
Mapping Report - Catalonia (Spain).
8–18 December 2015
Pan African Medical Journal 2017;27:215. doi: 10.11604/pamj.2017.27.215.12994
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
N°46/2012 of 14/01/2013 - Official Gazette n° Special of 17/01/2013 - LAW No 45/2012 OF 14/01/2013 ON ORGANISATION, FUNCTIONING AND COMPETENCE OF THE COUNCIL OF PHARMACISTS
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
